0001477449-24-000048.txt : 20240305
0001477449-24-000048.hdr.sgml : 20240305
20240305161116
ACCESSION NUMBER: 0001477449-24-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Napolitano Richard J
CENTRAL INDEX KEY: 0001599417
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 24720456
MAIL ADDRESS:
STREET 1: MSCI INC., 7 WORLD TRADE CENTER
STREET 2: 250 GREENWICH STREET, 49TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1709673064.xml
FORM 4
X0508
4
2024-03-01
0
0001477449
Teladoc Health, Inc.
TDOC
0001599417
Napolitano Richard J
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
CHIEF ACCOUNTING OFFICER
0
Common Stock
2024-03-01
4
M
0
1604
A
13353
D
Common Stock
2024-03-01
4
M
0
504
A
13857
D
Common Stock
2024-03-01
4
M
0
1481
A
15338
D
Common Stock
2024-03-01
4
M
0
337
A
15675
D
Common Stock
2024-03-01
4
M
0
565
A
16240
D
Common Stock
2024-03-01
4
M
0
894
A
17134
D
Common Stock
2024-03-01
4
M
0
4708
A
21842
D
Common Stock
2024-03-04
4
S
0
3765
14.516
D
18077
D
Performance Stock Units
2024-03-01
4
A
0
4814
0
A
Common Stock
4814
4814
D
Performance Stock Units
2024-03-01
4
M
0
1604
0
D
Common Stock
1604
3210
D
Performance Stock Units
2024-03-01
4
A
0
1515
0
A
Common Stock
1515
1515
D
Performance Stock Units
2024-03-01
4
M
0
504
0
D
Common Stock
504
1011
D
Restricted Stock Units
2024-03-01
4
M
0
1481
0
D
Common Stock
1481
2963
D
Restricted Stock Units
2024-03-01
4
M
0
337
0
D
Common Stock
337
1348
D
Restricted Stock Units
2024-03-01
4
M
0
565
0
D
Common Stock
565
2260
D
Restricted Stock Units
2024-03-01
4
M
0
894
0
D
Common Stock
894
4472
D
Restricted Stock Units
2024-03-01
4
M
0
4708
0
D
Common Stock
4708
9418
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2024, the reporting person earned 4,614 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2024, the reporting person earned 1,515 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On May 1, 2023, the reporting person was granted 4,444 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2022, the reporting person was granted 4,043 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On April 1, 2022, the reporting person was granted 6,778 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 14,126 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-03-05